UCAR-T for CD19+ Refractory/Relapsed B Hematologic Malignancies

Stopped No proper participant is found.

Conditions

• B-cell Lymphoma

Interventions

• BIOLOGICAL: CTA30X UCAR-T injection

Sponsor

920th Hospital of Joint Logistics Support Force of People's Liberation Army of China

Collaborators

• [object Object]